DJIA 17,817.90 7.84 0.04%
NASDAQ 4,754.89 41.92 0.89%
S&P 500 2,069.41 5.91 0.29%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

96.18 4.46 (4.86%)

REAL-TIME: Last trade at

Extended Hours: $96.19 $0.01 (0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ALNY $96.18 4.86%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.17
Previous Close $91.72
Daily Range $92.17 - $97.00
52-Week Range $47.03 - $112.57
Market Cap $7.4B
P/E Ratio -17.84
Dividend (Yield) $0.00 (0.0%)
Volume 950,123
Average Daily Volume 827,975
Current FY EPS -$5.26

Sector

Healthcare

Industry

Drugs

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary

Isis Pharmaceuticals Inc. Strikes Out on Its Own

Isis Pharmaceuticals uses its third-quarter earnings call to announce a reorganization as it pushes into late-stage development on its own.

Regulus To See Further Declines

Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14)

'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen

Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog

Alnylam Pharmaceuticals (ALNY) Weak On High Volume

Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog

Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog

Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALN-HDV For The Treatment Of Chronic Hepat

Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALN-HDV For The Treatment Of Chronic Hepatitis Delta Virus Infection And ALN-PDL For The Treatment Of Chronic Liver Infections

Alnylam Pharmaceuticals Staying Ridiculously Busy

Alnylam's Q3 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog

See More ALNY News...

ALNY's Top Competitors

ALNY $96.18 (4.86%)
Current stock: ALNY
AMGN $164.18 (0.84%)
Current stock: AMGN
GILD $100.60 (0.02%)
Current stock: GILD
BIIB $306.74 (1.05%)
Current stock: BIIB